Display options
Cite
Kaya D, Kaya M, Özakbaş S, et al. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol. 2014;7(6):1010-3doi: 10.3980/j.issn.2222-3959.2014.06.18.
Kaya, D., Kaya, M., Özakbaş, S., & İdiman, E. (2014). Uveitis associated with multiple sclerosis: complications and visual prognosis. International journal of ophthalmology, 7(6), 1010-3. https://doi.org/10.3980/j.issn.2222-3959.2014.06.18
Kaya, Derya, et al. "Uveitis associated with multiple sclerosis: complications and visual prognosis." International journal of ophthalmology vol. 7,6 (2014): 1010-3. doi: https://doi.org/10.3980/j.issn.2222-3959.2014.06.18
Kaya D, Kaya M, Özakbaş S, İdiman E. Uveitis associated with multiple sclerosis: complications and visual prognosis. Int J Ophthalmol. 2014 Dec 18;7(6):1010-3. doi: 10.3980/j.issn.2222-3959.2014.06.18. eCollection 2014. PMID: 25540756; PMCID: PMC4270967.
Copy Download .nbib Format: NLM
Share it on

Int J Ophthalmol. 2014 Dec 18;7(6):1010-3. doi: 10.3980/j.issn.2222-3959.2014.06.18. eCollection 2014.

Uveitis associated with multiple sclerosis: complications and visual prognosis.

International journal of ophthalmology

Derya Kaya, Mahmut Kaya, Serkan Özakbaş, Egemen İdiman

Affiliations

  1. Department of Geriatrics Medicine, Dokuz Eylul University, Izmir 35340, Turkey.
  2. Department of Ophthalmology, Dokuz Eylul University, Izmir 35340, Turkey.
  3. Department of Neurology, Dokuz Eylul University, Izmir 35340, Turkey.

PMID: 25540756 PMCID: PMC4270967 DOI: 10.3980/j.issn.2222-3959.2014.06.18

Abstract

AIM: To determine the frequency, subtype, complications, treatment and visual prognosis of uveitis in patients with multiple sclerosis (MS).

METHODS: A total of 1702 MS patients' medical records were reviewed for a history of uveitis both with a neurologist and an ophthalmologist.

RESULTS: Nine patients (0.52%) with uveitis were detected. Eight of them were female, one was male. The mean age was 42.0±14.1y (range 22-66). Seven patients were relapsing remitting MS, two were secondary progressive MS. The mean duration of MS was 10.8±10.3y, and the mean duration of uveitis 10.3±9.9y. The onset of uveitis preceded that of MS (four patients) by a mean of 5.0±4.3y (range 1-11). MS diagnosed prior to the onset of uveitis (five patients) by an interval of 0.75-16y (mean 4.95±6.24y). There were 16 affected eyes of nine patients. The most common types of uveitis were panuveitis and intermediate uveitis. Uveitis was bilateral in most patients. The most common complications were cataract and glaucoma, and patients with such complications were surgically treated. The range of visual acuity of affected eyes was 20/800 to 20/22, with only six of 16 affected eyes better than 20/40. After treatment, the visual acuity of the affected eyes was better than 20/40 in 11 of 16 eyes.

CONCLUSION: Uveitis should be considered when assessing an MS patient with visual loss, as surgical interventions other than medical treatments may be needed to improve visual function. Complications could be seen more often when posterior segment is involved.

Keywords: complication; multiple sclerosis; uveitis; visual acuity

References

  1. Ophthalmic Res. 2013;49(1):25-9 - PubMed
  2. Bull Soc Belge Ophtalmol. 2009;(313):65-8 - PubMed
  3. Neurology. 1999 Jan 1;52(1):179-81 - PubMed
  4. Am J Ophthalmol. 1987 Feb 15;103(2):234-5 - PubMed
  5. Ophthalmology. 1991 Feb;98(2):142-5 - PubMed
  6. Mult Scler Int. 2012;2012:372361 - PubMed
  7. Graefes Arch Clin Exp Ophthalmol. 1993 Mar;231(3):166-8 - PubMed
  8. J Neurol Sci. 2001 Jun 15;187(1-2):49-53 - PubMed
  9. Lancet. 2002 Apr 6;359(9313):1221-31 - PubMed
  10. Neurology. 1997 Nov;49(5):1404-13 - PubMed
  11. Annu Rev Immunol. 1992;10:153-87 - PubMed
  12. Ophthalmology. 1999 Mar;106(3):594-9 - PubMed
  13. Ocul Immunol Inflamm. 2004 Jun;12(2):137-42 - PubMed
  14. Arch Soc Esp Oftalmol. 2012 Oct;87(10):324-9 - PubMed
  15. Ophthalmology. 1993 Jun;100(6):818-24; discussion 825 - PubMed
  16. Br J Ophthalmol. 2004 Dec;88(12):1498-9 - PubMed
  17. Am J Ophthalmol. 1992 Jan 15;113(1):28-32 - PubMed
  18. Mult Scler. 2011 Dec;17(12):1464-71 - PubMed
  19. Ann Neurol. 1983 Mar;13(3):227-31 - PubMed
  20. Mult Scler. 2008 Apr;14(3):415-7 - PubMed
  21. Ocul Immunol Inflamm. 2011 Feb;19(1):19-25 - PubMed
  22. Vojnosanit Pregl. 2011 Jul;68(7):544-9 - PubMed
  23. Eur J Ophthalmol. 2014 Jan-Feb;24(1):94-100 - PubMed
  24. Clin Exp Ophthalmol. 2000 Apr;28(2):97-102 - PubMed

Publication Types